Vitiligo occurs worldwide with a prevalence of less than 0.5% to 1-2% depending on the population. Adults and children of both sexes are affected. The exact mechanism of the cause of disease is poorly understood, but there is definitely a slow or no production of melanin pigments because of many reasons. The autoimmune component is also said to be associated, though we do not agree to this theory fully. Stage wise, Vitiligo can be newly occurring, established one, or a long standing patch. Classified on the basis of areas involved, it can be Vitiligo Vulgaris [non segmental], or the segmental variety. The treatments designed, aim at increasing the melanocyte production and proliferation at the DNA level.